The role of RNA binding proteins in hepatocellular carcinoma.

Adv Drug Deliv Rev

Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States; Sidney Kimmel Cancer Center, Philadelphia, PA, United States. Electronic address:

Published: March 2022

Hepatocellular carcinoma (HCC) is one of the leading causes of overall cancer deaths worldwide with limited therapeutic options. Due to the heterogeneity of HCC pathogenesis, the molecular mechanisms underlying HCC development are not fully understood. Emerging evidence indicates that RNA-binding proteins (RBPs) play a vital role throughout hepatocarcinogenesis. Thus, a deeper understanding of how RBPs contribute to HCC progression will provide new tools for early diagnosis and prognosis of this devastating disease. In this review, we summarize the tumor suppressive and oncogenic roles of RBPs and their roles in hepatocarcinogenesis. The diagnostic and therapeutic potential of RBPs in HCC, including their limitations, are also discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2022.114114DOI Listing

Publication Analysis

Top Keywords

hepatocellular carcinoma
8
hcc
5
role rna
4
rna binding
4
binding proteins
4
proteins hepatocellular
4
carcinoma hepatocellular
4
carcinoma hcc
4
hcc leading
4
leading cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!